Michael Restuccia, SVP & CIO, Penn Medicine Rarely is the phrase “drinking the Kool-Aid” considered a good thing — and even rarer is it cited as the reason for staying with an organization. But in Michael Restuccia’s case, it makes perfect sense. When he was offered an opportunity to lead an IS project at Penn… Read More »
As he is approaching his subject philosophically, he’s taking careful steps at every stage of his argument. His first goal is to examine how philosophers have dealt with the instability of the definition of race, and how their accounts of race could be ameliorative or useful in medical contexts. “My overarching hypothesis is that a… Read More »
According to Moloney, who developed Game Changers in Medicine‘s concept, “Many significant advances in medicine owe a lot to coincidence and plain dumb luck. Some of the most important achievements in healthcare were the result of fortuitous accidents followed by scientific rigor. But serendipity and science alone don’t improve health and healthcare. It took curious,… Read More »
Email Tweet Stanford Medicine trial to test favipiravir for treating COVID-19 outpatients Researchers want to determine whether favipiravir, an oral drug, is effective in reducing the severity of symptoms and shortening the duration of COVID-19. Jun 30 2020 Aruna Subramanian is investigating an antiviral drug, favipiravir, to see if it reduces symptoms and viral shedding… Read More »